ReviewJournal of clinical medicine2026
Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and Trastuzumab Deruxtecan.
Piotr Kawczak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.